1. Field of the Disclosure
The present disclosure relates generally to a tensioning control device. More particularly, the present disclosure relates to a tensioning control device for a labeling device for a syringe.
2. Description of the Related Art
Syringes need to include information to help medical professionals identify the contents of the syringes. Errors such as giving an incorrect medication or an incorrect dose can easily be made if the contents of the syringe cannot be positively identified from the point of time that a medication is transferred to a syringe up to the moment of its administration.
The results of missed and unintended medication include adverse effects to patients and significant costs to the healthcare industry. Potential causes for these errors include unclear syringe contents due to unlabeled or poorly labeled syringes and poor record keeping of which drugs were administered and the concentration and quantity of the administered drug.
Identifying the content of a syringe based on the appearance of that content is unreliable. Visual identification of the medication is very difficult since several of the medications are identical or nearly identical in appearance.
The present disclosure provides a tensioning control device having a first motor that applies a torque to a first end of a substrate in a first direction and a second motor that applies a torque to a second end of the substrate in a second direction that is generally opposite the first direction. In this manner, the first motor and the second motor apply torque to the substrate in opposing directions, thereby placing the substrate in tension. In one embodiment, the first motor applies a torque to the first end of the substrate that is equal to the torque applied to the second end of the substrate by the second motor. By placing the substrate in tension in this manner, an actuator is able to incrementally move the substrate in a forward direction and a backward direction independent of the tension applied to the substrate.
In accordance with an embodiment of the present invention, a tensioning control device includes a substrate having a first end and an opposing second end; a first motor applying a first torque to the first end of the substrate in a first direction; and a second motor applying a second torque to the second end of the substrate in a second direction, the second direction generally opposite the first direction thereby placing the substrate in tension.
In one configuration, the first torque applied to the first end of the substrate is equal to the second torque applied to the second end of the substrate. In another configuration, the tensioning control device further includes an actuator adapted to move the substrate in a forward direction and a backward direction. In yet another configuration, the actuator is adapted to move the substrate in the forward direction and the backward direction independent of the tension applied to the substrate. In one configuration, the actuator is adapted to incrementally move the substrate. In another configuration, the actuator is a printing mechanism. In yet another configuration, the substrate is a material adapted to receive information for a label for a syringe.
In accordance with another embodiment of the present invention, a tensioning control device includes a substrate having a first end and an opposing second end; a first motor applying a first torque to the first end of the substrate in a first direction; a second motor applying a second torque to the second end of the substrate in a second direction, the second direction generally opposite the first direction thereby placing the substrate in tension; and an actuator adapted to move the substrate in a forward direction and a backward direction independent of the tension applied to the substrate.
In one configuration, the first torque applied to the first end of the substrate is equal to the second torque applied to the second end of the substrate. In another configuration, the actuator is adapted to incrementally move the substrate. In yet another configuration, the actuator is a printing mechanism. In one configuration, the substrate is a material adapted to receive information for a label for a syringe.
In accordance with another embodiment of the present invention, a labeling subsystem for a labeling device for a syringe includes a material adapted to receive information for a label for the syringe, the material having a first end and an opposing second end; a first motor applying a first torque to the first end of the material in a first direction; a second motor applying a second torque to the second end of the material in a second direction, the second direction generally opposite the first direction thereby placing the material in tension; and an actuator adapted to move the material in a forward direction and a backward direction independent of the tension applied to the material.
In one configuration, the labeling subsystem further includes a printer adapted to print the information on the material. In another configuration, the labeling subsystem further includes a removal device adapted to automatically remove a backing material from the material. In yet another configuration, the first torque applied to the first end of the material is equal to the second torque applied to the second end of the material. In one configuration, the actuator is adapted to incrementally move the material. In another configuration, the actuator is a printing mechanism.
The above-mentioned and other features and advantages of this disclosure, and the manner of attaining them, will become more apparent and the disclosure itself will be better understood by reference to the following descriptions of embodiments of the disclosure taken in conjunction with the accompanying drawings, wherein:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate exemplary embodiments of the disclosure, and such exemplifications are not to be construed as limiting the scope of the disclosure in any manner.
The following description is provided to enable those skilled in the art to make and use the described embodiments contemplated for carrying out the invention. Various modifications, equivalents, variations, and alternatives, however, will remain readily apparent to those skilled in the art. Any and all such modifications, variations, equivalents, and alternatives are intended to fall within the spirit and scope of the present invention.
For purposes of the description hereinafter, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the invention as it is oriented in the drawing figures. However, it is to be understood that the invention may assume various alternative variations, except where expressly specified to the contrary. It is also to be understood that the specific devices illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments of the invention. Hence, specific dimensions and other physical characteristics related to the embodiments disclosed herein are not to be considered as limiting.
Labeling device 10 is compatible with a plurality of different syringes. For example, labeling device 10 is compatible with any syringe available from Becton, Dickinson and Company of Franklin Lakes, N.J. In one embodiment, labeling device 10 is compatible with any luer lock syringe available from Becton, Dickinson and Company of Franklin Lakes, N.J.
Referring to
Referring to
Distal end 32 of syringe barrel 24 includes an outlet opening 38 which is in fluid communication with chamber 36. Outlet opening 38 may be sized and adapted for engagement with a separate device, such as a needle assembly or IV connection assembly and, therefore, may include a mechanism for such engagement as is conventionally known. In one embodiment, distal end 32 may include a generally-tapered luer tip 42 for engagement with an optional separate tapered luer structure of such a separate device for attachment therewith such as needle 44. In one configuration, both the tapered luer tip 42 and the separate tapered luer structure may be provided with syringe 12. In such a configuration, the separate tapered luer structure may be fitted with an attachment mechanism, such as a threaded engagement, for corresponding engagement with a separate device such as needle 44. In another configuration, tapered luer tip 42 may be provided for direct engagement with a separate device such as needle 44. In one embodiment, needle 44 includes a needle hub 48 for engagement to distal end 32 of syringe barrel 24. In addition, a mechanism for locking engagement therebetween may also be provided with at least one of tapered luer tip 42 and/or the separate tapered luer structure, such as a luer collar or luer lock including interior threads. Such luer connections and luer locking mechanisms are well known in the art.
Proximal end 34 of syringe barrel 24 is generally open-ended, but is intended to be closed off to the external environment as discussed herein. Syringe barrel 24 may also include markings, such as graduations located on sidewall 30, for providing an indication as to the level or amount of fluid contained within interior chamber 36 of syringe barrel 24. Such markings may be provided on an external surface of sidewall 30, an internal surface of sidewall 30, or integrally formed or otherwise within sidewall 30 of syringe barrel 24. In other embodiments, alternatively, or in addition thereto, the markings may also provide a description of the contents of the syringe or other identifying information as may be known in the art, such as maximum and/or minimum fill lines.
In some embodiments, syringe 12 may be useful as a pre-filled syringe, and, therefore, may be provided for end use with a fluid, such as a medication or drug, contained within interior chamber 36 of syringe barrel 24, pre-filled by the manufacturer. In this manner, syringe 12 can be manufactured, pre-filled with a medication, sterilized, and packaged in appropriate packaging for delivery, storage, and use by the end user. In such embodiments, syringe 12 may include a sealing cap member disposed at distal end 32 of syringe barrel 24 to seal a fluid, such as a medication, within interior chamber 36 of syringe barrel 24.
Referring to
Referring to
Referring to
Labeling device 10 provides an encoded syringe labeler for the labeling of syringes in a medical setting such as an operating room, pharmacy, or perioperative space of a hospital. Referring to
The labeling device 10 includes a top door 66 located at top portion 50. In one embodiment, top door 66 may be connected to top portion 50 of housing 14 by a hinged portion 68. In this manner, top door 66 may be transitioned between a closed position and an open position as shown in
The labeling device 10 includes a label slot or opening 76 located at front portion 54 of housing 14 of labeling device 10. The label slot 76 provides an exit portion for a second label 300 having human readable information 302 as described in more detail below, and shown in
In one embodiment, the scanner 20 is located on front portion 54 of housing 14 of labeling device 10. The scanner 20 is adapted to scan a portion of a container having a medication therein to retrieve medication information for the medication contained in the container. For example, in one embodiment, the scanner 20 may scan a barcode located on a container having a medication therein. Upon scanning the container with the scanner 20, the medication information about the medication contained in the container is processed by the labeling device 10. For example, the labeling device 10 may refer to a database to process the medication information about the medication contained in the container. In one embodiment, the labeling device 10 may refer to a centralized database to process the medication information about the medication contained in the container. In another embodiment, the labeling device 10 may refer to a local database stored in the labeling device 10 to process the medication information about the medication contained in the container. A user may then select to analyze and/or modify this medication information using the onboard touchscreen interface 22. Potential data fields requiring modification include drug concentration, combinations, and/or other medication identifying information. In one embodiment, the touchscreen interface 22 that is adapted to display the medication information is located on the front portion 54 of housing 14 of labeling device 10.
Referring to
Referring to
The machine readable information 102 conforms to all applicable standards regarding information contained on a label for a syringe. In one embodiment, the machine readable information 102 is a barcode. For example, the machine readable information 102 may be a unique barcode that is able to record and transmit information related to the syringe and the medication contained therein. Referring to
Referring to
Referring to
The holding element 110 provides a gripping surface that allows a user to pick up the clamp assembly 106 without having to place their hand within the syringe receiving port 104. In this manner, with the syringe 12 received within the receiving port 104, a user can remove the syringe 12 and/or clamp assembly 106, if needed, without having to place their hand within the syringe receiving port 104 and without having to touch the syringe 12. In one embodiment, the holding element 110 includes a lip portion 130 that extends beyond the periphery of the other components of the clamp assembly 106. In this manner, a user can grasp the holding element 110 at the lip portion 130 to remove the syringe 12 and/or clamp assembly 106. In one embodiment, the outer diameter of the holding element 110 is greater than the outer diameter of the other components of the clamp assembly 106. The holding element 110 includes a central aperture 132 adapted to receive the syringe 12 therethrough.
The drive gear 112 interfaces with a motor and is adapted to open and close the gripping components 120 that are adapted to grip the syringe 12 with the gripping components 120 in the closed position. The motor provides a drive mechanism to rotate the drive gear 112. Additionally, the drive gear 112 is adapted to rotate the syringe 12 during the automatic application of the first label 100 to the syringe 12. In one embodiment, the drive gear 112 includes teeth 134, a first cam slot 136 adapted to receive a first cam post 138, a second cam slot 140 adapted to receive a second cam post 142, a third cam slot 144 adapted to receive a third cam post 146, and a central aperture 148 adapted to receive the syringe 12 therethrough.
The alignment disc 114 is adapted to properly align and maintain the position of the components of the clamp assembly 106. In one embodiment, the alignment disc 114 includes a superior surface 150, an opposing inferior surface 152, a plurality of retaining posts 154 extending from the inferior surface 152, a bearing 156 disposed on each of the retaining posts 154, and a central aperture 158 adapted to receive the syringe 12 therethrough. In one embodiment, the alignment disc 114 includes three retaining posts 154 each having a bearing 156 thereon.
The alignment disc 114 is adapted to allow the components of the clamp assembly 106 to rotate independently of each other so that the gripping components 120 can be opened and closed to grip the syringe 12 with the gripping components 120 in the closed position. Once the gripping components 120 are moved to the closed position to grip the syringe 12, the components of the clamp assembly 106 are then capable of rotating together to rotate the syringe 12 during the automatic application of the first label 100 to the syringe 12. In one embodiment, the syringe 12 is rotated during the automatic application of the first label 100 to the syringe 12 while the first label 100 remains in a stationary position.
The carrier component 116 includes a gear 118 extending around the periphery of the carrier component 116, protruding walls 170 each defining a rod aperture 172, and a central aperture 174 adapted to receive the syringe 12 therethrough. The carrier component 116 provides a carrier that the other components of the clamp assembly 106 can be secured to. In one embodiment, the carrier component 116 is formed of steel, although other materials of similar strength may be used. The components of the clamp assembly 106 can be secured to the carrier component 116 using methods known in the art. In one embodiment, any suitable fastener can be used to secure the components of the clamp assembly 106 to the carrier component 116 such as a bolt or a threaded fastener. The carrier component 116 includes protruding walls 170 that define rod apertures 172 therethrough. The protruding walls 170 extend from the carrier component 116 inward to the central aperture 174. In one embodiment, the carrier component 116 includes three protruding walls 170 each defining a rod aperture 172. The carrier component 116 also includes the central aperture 174 adapted to receive the syringe 12 therethrough.
The gripping components 120 are movable between an open position (
In one embodiment, the gripping components 120 are adapted to securely hold any size of syringe 12 within the syringe receiving port 104 while the label print and apply assembly 108 automatically applies a first label 100 to the luer tip 42 of the syringe 12. In other embodiments, the gripping components 120 are adapted to securely hold a syringe 12 having any size from 1 mL to 60 mL within the syringe receiving port 104 while the label print and apply assembly 108 automatically applies a first label 100 to the luer tip 42 of the syringe 12.
The retaining ring 122 includes a superior surface 186, an opposing inferior surface 188, a plurality of posts 190 extending from the inferior surface 188 and each defining a rod receiving aperture 192, and a central aperture 194 adapted to receive the syringe 12 therethrough.
Referring to
Movement of the jaws 160, 162, 164 between the open position and the closed position is controlled by a movable cam connection between the jaws 160, 162, 164 and the drive gear 112. In one embodiment, the respective cam slots 136, 140, 144 of the drive gear 112 are aligned with the cam post receiving apertures 168 of the respective jaws 160, 162, 164. In this manner, cam posts 138, 142, 146 can be positioned through the respective cam slots 136, 140, 144 of the drive gear 112 and through the cam post receiving apertures 168 of the respective jaws 160, 162, 164 to movably connect the jaws 160, 162, 164 to the drive gear 112. In this manner, the drive gear 112 controls movement of the jaws 160, 162, 164 between the open position and the closed position.
In one embodiment, the first cam slot 136, the second cam slot 140, and the third cam slot 144 are positioned off-center so that rotation of the drive gear 112 with the carrier component 116 in a stationary position moves the jaws 160, 162, 164 between the open position and the closed position via the sliding movement of the cam posts 138, 142, 146 within the off-center cam slots 136, 140, 144.
Referring to
The syringe alignment component 126 is removably connected to the stability ring 124. The syringe alignment component 126 includes flexible arms 127, a wall 128 that extends downwardly from the syringe alignment component 126, a luer tip receiving portion 129, an alignment area 131, and a central aperture 133 adapted to receive the luer tip 42 of the syringe 12 therethrough. In one embodiment, the syringe alignment component 126 is removably connected to the stability ring 124 via a snap fit engagement. For example, the flexible arms 127 can be used to snap fit the syringe alignment component 126 to the stability ring 124. The flexible arms 127 can be deformed to an open position so that the syringe alignment component 126 can be removed from the stability ring 124. With the syringe 12 positioned within the syringe receiving port 104, the luer tip 42 of the syringe 12 extends beyond the central aperture 133 to the luer tip receiving portion 129 within the alignment area 131. In this manner, the luer tip 42 of the syringe 12 is properly positioned within the first labeling subsystem 16 so that an optical syringe alignment unit 250 (
A syringe clamp assembly of the first labeling subsystem 16 may include other embodiments to securely hold a syringe 12 within the syringe receiving port 104 while the label print and apply assembly 108 automatically applies a first label 100 to the luer tip 42 of the syringe 12.
Referring to
Referring to
In another embodiment, a syringe clamp assembly of the present disclosure includes a cap clamp assembly. In this embodiment, the cap clamp assembly utilizes a collet to grab a syringe cap and pull it against a datum surface for axial registration. The cap clamp assembly would also rotate the syringe 12 similar to the opposing V-shaped clamp assembly and the oblique roller clamp assembly for automatic application of a first label 100 to the luer tip 42 of the rotating syringe 12.
Referring to
The label print and apply assembly 108 includes a sensor component 210 having a sensor arm 212 that is used as a photo interrupter and a cam element 214. The sensor component 210 is rotatable between a first position and a second position. In one embodiment, the sensor component 210 interfaces with a motor. The motor provides a drive mechanism to rotate the sensor component 210 between the first position and the second position. In one embodiment, with the sensor component 210 rotated to the second position, the sensor arm 212 breaks an optical beam. In this manner, the position of the sensor component 210 is determined and the label print and apply assembly 108 can be activated in accordance with the position of the sensor component 210. In one embodiment, rotation of the sensor component 210 moves the cam element 214 between a first position and a second position.
The label print and apply assembly 108 includes a print and apply state controller 218 that activates the first label print assembly 200 to print a first label 100 and activates the label apply assembly 202 to automatically apply the first label 100 to a syringe 12. In one embodiment, the print and apply state controller 218 includes a first flipper arm 220 and a second flipper arm 222 which are spring loaded. In one embodiment, the first flipper arm 220 and the second flipper arm 222 are spring loaded by a spring 224. The first flipper arm 220 and the second flipper arm 222 are movable between a first position, in which the first label print assembly 200 is activated to print a first label 100, and a second position, in which the label apply assembly 202 is activated to automatically apply the first label 100 to a syringe 12. In one embodiment, the first flipper arm 220 and the second flipper arm 222 interface with the cam element 214. Thus, rotation of the cam element 214 between a first position and a second position moves the first flipper arm 220 and the second flipper arm 222 between the first position and the second position.
The first flipper arm 220 and the second flipper arm 222 control pressure rollers on the label path that allow the first label 100 to be printed via the first label print assembly 200 or applied via the label apply assembly 202. For example, in one embodiment, with the first flipper arm 220 and the second flipper arm 222 in a first position, the flipper arms 220, 222 control a first pressure roller to force a cartridge, spool, or reel containing a label up against a label printer head 230 and feeds the label through the label printer head 230 for the printing of machine readable information on a first label 100. Referring to
After printing, the first flipper arm 220 and the second flipper arm 222 can be rotated to a second position so that the first pressure roller is disconnected from the label path and a second pressure roller clamps down and feeds the first label 100 containing machine readable information forward for the peeling off of the first label 100 from a backing material for the automatic application of the first label 100 to a syringe 12.
The label print and apply assembly 108 includes a mounting plate 232 for controlling the position and securing the components of the label print and apply assembly 108. In one embodiment, the components of the label print and apply assembly 108 can be secured to the mounting plate 232 using fasteners and methods known in the art.
The label print and apply assembly 108 includes a first motor 234, a second motor 236, a third motor 238, and a fourth motor 240 to operate the label print and apply assembly 108. In one embodiment, the first motor 234 and the second motor 236 are stepper motors which allow for the indexing and controlling of the position of the first label 100 so that the printing of the machine readable information onto the first label 100 is printed and applied properly.
In one embodiment, the third motor 238 and the fourth motor 240 provide tension to the reel of labels so that the labels are held tightly and do not wrinkle, tangle, and/or crease. In this manner, the printing of the machine readable information onto the first label 100 is printed and applied properly to the first label 100.
Referring to
The mounting bracket 256 is adapted to connect the optical syringe alignment unit 250 so that the first camera 252 and the second camera 254 are positioned adjacent the alignment area 131 of the syringe positioning and alignment component 126. In one embodiment, the mounting bracket 256 is connectable to an interior wall portion of the housing 14 of the labeling device 10.
Referring to
The pinch roller mechanism 260 includes a roller contact portion 262, a pivotable frame member 264, and a solenoid 266 including an actuation member 268. The solenoid 266 is adapted to move the actuation member 268 forward and backward. The pivotable frame member 264 is movably connected to the actuation member 268 of the solenoid 266. Movement of the actuation member 268 of the solenoid 266 forward causes the frame member 264 to pivot such that the roller contact portion 262 can be positioned to contact a portion of the first label 100 as the first label 100 is automatically being applied to the luer tip 42 of the syringe 12 to ensure that the first label 100 is securely applied to the syringe 12. In one embodiment, the frame member 264 includes a receiving aperture 270 and the roller contact portion 262 includes a rod 272 that is received within the receiving aperture 270 so that the roller contact portion 262 is rotatably connected to the frame member 264.
Referring to
In one embodiment, the second labeling subsystem 18 includes components that allow the second labeling subsystem 18 to automatically apply a second label 300 to a portion of the syringe 12. In one embodiment, the second labeling subsystem 18 automatically applies a second label 300 to a portion of the syringe 12 simultaneously with the first labeling subsystem 16 automatically applying a first label 100 to a portion of the syringe 12.
The human readable information 302 may be in full color and conforms to all applicable standards regarding layout and information contained on a label for a syringe. In this manner, the labeling device 10 provides a first label 100 having machine readable information 102 and a second label 300 having human readable information 302 so that a user and/or a machine can easily obtain the desired information regarding the syringe 12 and the contents therein. In one embodiment, the second label 300 may be printed using an inkjet printer so that the human readable information 302 may be in full color.
Referring to
The second label actuator 322, the second gear system 326, and the second motor 324 are movably secured to the second mounting portion 328. The second mounting portion 328 is adapted to secure the gears of the second gear system 326 to the second mounting portion 328 to control the position of the gears of the second gear system 326. In one embodiment, the second mounting portion 328 is formed of sheet metal.
In one embodiment, the first gear system 316 is adapted to provide an arrangement that can be used to increase the strength of the first motor 314. For example, the first gear system 316 is adapted to provide an arrangement that can be used to increase the power, e.g., torque, and/or speed of the first motor 314. In one embodiment, the second gear system 326 is adapted to provide an arrangement that can be used to increase the strength of the second motor 324. For example, the second gear system 326 is adapted to provide an arrangement that can be used to increase the power, e.g., torque, and/or speed of the second motor 324.
In one embodiment, the mounting plate 336 is adapted to secure the components of the second labeling subsystem 18 to the mounting plate 336 to control the position of the components of the second labeling subsystem 18. In one embodiment, the mounting plate 336 is formed of sheet metal.
The first motor 314 provides a mechanism to control the torque applied to the first label roll 310 in a first direction generally along arrow A (
By placing the substrate or movable label portion 330 in tension in the manner described above, an actuator or index control system 334 is able to incrementally move the movable label portion 330 back and forth independent of the tension applied to the movable label portion 330. For example, the index control system 334 is adapted to move the label portion 330 in a forward direction and a backward direction. The second labeling subsystem 18 allows for precise control of the movement of the movable label portion 330. For example, the second labeling subsystem 18 allows for independent control of the tension applied to the movable label portion 330, the position of a given point on the movable label portion 330, and the speed at which the movable label portion 330 travels. The second labeling subsystem 18 allows for the precise control of the movement of the movable label portion 330 to control the application of a secondary material to the movable label portion 330, the printing of the human readable information on the movable label portion 330 to form a second label 300, and the cutting of the second label 300 from the movable label portion 330 using a cutting mechanism. The cutting mechanism may include a knife, laser, or water jet printing cutting mechanism.
In one embodiment, the first motor 314 and the second motor 324 are servomotors with closed loop feedback to maintain the proper tension applied to the movable label portion 330. In another embodiment, the first motor 314 and the second motor 324 are brushed DC motors driven by a PWM signal in a torque control mode. In other embodiments, other motors are used to apply tension to the movable label portion 330. For example, the first motor 314 and the second motor 324 may be servo or stepper motors with a closed or open loop feedback to maintain the proper tension applied to the movable label portion 330.
The index control system 334 can include any drive mechanism adapted to move the movable label portion 330 back and forth. In one embodiment, the index control system 334 is a printing mechanism. In other embodiments, other drive mechanisms may be used. In some embodiments, a laser cut printing mechanism, a water jet printing mechanism, or a knife cut printing mechanism may be used.
After the human readable information 302 is printed onto a second label 300, the second label 300 is moved towards an exit area 344 for automatic removal of the backing material 304 of the second label 300. In one embodiment, the second labeling subsystem 18 includes a removal device 332 adapted to automatically remove the backing material 304 of the second label 300. In one embodiment, the removal device 332 comprises a wall that contacts the backing material 304 of the second label 300 as the second label 300 is advanced towards the exit area 344 for removal of the second label 300 from the labeling device 10. In this manner, as the second label 300 advances towards the exit area 344, the removal device 332 contacts the backing material 304 and provides a physical barrier that removes the backing material 304 from the second label 300 as the second label 300 is able to advance beyond the removal device 332. The removal device 332 is dimensioned so that the wall of the removal device 332 contacts the backing material 304 but does not contact the second label 300 so that the second label 300 advances past the removal device 332 while the removal device 332 automatically removes the backing material 304. In one embodiment, the removal device is a wall or edge of sheet metal.
After the second label 300 advances past the removal device 332 and the backing material 304 is removed, the second label 300 advances past the label slot 76 at the front portion 54 of the housing 14 of the labeling device 10 as shown in
The user does not have to remove the backing material 304 from the second label 300 because the second labeling subsystem 18 has already automatically removed the backing material 304. Requiring a user such as a medical practitioner to manually remove the backing material 304 from the second label 300 can be a difficult and time consuming process, especially considering the user will be wearing gloves. Also, the user would have to dispose of the backing material 304 every time a second label 300 was printed. Further, the user would have to put down the syringe 12 the second label 300 was meant for, potentially causing confusion if placed near other, similar syringes on a table top or tray.
Referring to
Referring to
Next, the gripping components 120 are moved to the closed position to contact and grip the syringe 12. As the gripping components 120 are moved to the closed position, the gripping components 120 also center the syringe 12 to the proper orientation within the clamp assembly 106 for the automatic application of the first label 100 to the syringe 12. In one embodiment, the drive gear 112 controls the movement of the gripping components 120 between the open position and the closed position via the movable cam connection between the drive gear 112 and the gripping components 120, e.g., cam posts 138, 142, 146 connecting the gripping components 120 and the drive gear at the cam slots 136, 140, 144. In this manner, the syringe clamp assembly 106 securely holds syringe 12 while the label print and apply assembly 108 automatically applies a first label 100 to the luer tip 42 of the syringe 12. Advantageously, the automatic application of the first label 100 to the syringe 12 using labeling device 10 eliminates the potential for misapplication of the first label 100 or human error.
Next, the print and apply state controller 218 of the label print and apply assembly 108 activates the first label print assembly 200 to print a first label 100. After printing of the first label 100, the print and apply state controller 218 activates the label apply assembly 202 to automatically apply the first label 100 to the luer tip 42 of the syringe 12. To facilitate the automatic application of the first label 100 to the syringe 12, the components of the clamp assembly 106 rotate together to rotate the syringe 12 during the automatic application of the first label 100 to the syringe 12. In one embodiment, the syringe 12 is rotated during the automatic application of the first label 100 to the syringe 12 while the first label 100 remains in a stationary position. To ensure the first label 100 is securely applied to the syringe 12, outward movement of the actuation member 268 of the solenoid 266 causes the frame member 264 to pivot such that the roller contact portion 262 can be positioned to contact a portion of the first label 100 as the first label 100 is automatically being applied to the luer tip 42 of the syringe 12. In one embodiment, the first label 100 is of a sufficient length so that as the first label 100 is applied to the luer tip 42 of the syringe 12, the first label 100 wraps around the luer tip 42 and a portion of the first label 100 overlaps itself. In this manner, the first label 100 is securely attached to a luer tip 42 that may have a lubricant or other fluid on it.
As the operation of the printing and automatic application of the first label 100 to the syringe 12 is occurring, the second labeling subsystem 18 can print the second label 300 including human readable information 302 as described above.
As described above, the first motor 314 and the second motor 324 apply torque to the respective first label roll 310 and the second label roll 320 in opposing directions, thereby placing the movable label portion 330 in tension. By placing the movable label portion 330 in tension, an index control system 334 is able to incrementally move the movable label portion 330 back and forth independent of the tension applied to the movable label portion 330. The second labeling subsystem 18 allows for independent control of the tension applied to the movable label portion 330, the position of a given point on the movable label portion 330, and the speed at which the movable label portion 330 travels.
After the human readable information 302 is printed onto a second label 300, the second label 300 is moved towards the exit area 344 for automatic removal of the backing material 304 of the second label 300 via the removal device 332.
After the first label 100 is printed and automatically applied to the luer tip 42 of the syringe 12, a user is able to remove the syringe 12 from the labeling device 10. Next, the user can easily remove the second label 300 from the label slot 76 and position the second label 300 on the syringe 12. Advantageously, the user does not have to remove the backing material 304 from the second label 300 as the second labeling subsystem 18 has already automatically removed the backing material 304. Next, the syringe 12 may be used to administer a medication as is known in the art.
The labeling device 10 provides for a syringe 12 having a first label 100 including machine readable information 102 and a second label 300 including human readable information 302 as shown in
A syringe 12 having a first label 100 including machine readable information 102 and a second label 300 including human readable information 302 provides encoded syringes that can be utilized along with the EMR system of a hospital to track drug administration, check for potential allergies or drug interactions, and/or other important information, all without the need for human intervention.
The labeling device 10 is envisioned to be a part of a larger system solution to combat medication errors. For example, the labeling device 10 works to eliminate the following adverse effects that can be caused by medication errors: (1) unclear syringe contents from unlabeled or poorly labeled syringes; (2) allergic reactions; (3) drug interactions; and (4) poor record keeping, e.g., which drugs were administered, concentration, and/or quantity of drug.
It is envisioned that other potential methods may be used with the labeling device 10 of the present disclosure for linking each syringe to specific information regarding the drugs contained within the syringe and patient information. For example, the machine readable information 102 on the first label 100 may comprise any mechanism for transmitting specific information regarding the drugs contained within the syringe and patient information. In one embodiment, a radio-frequency identification (RFID) system may be used. Empty syringes may come preloaded with an RFID or an RFID label would be applied. The labeling device 10 would read the code and add that information to a database, tying the syringe to the drug and concentration the syringe contains as well as which patient it was intended for. In such a system, it would also be possible to add information to the unique RFID from a database.
In one embodiment, a near field communication system may be used. Such a system would include similar implementation to the RFID system discussed above.
In one embodiment, a laser marking system may be used. The labeling device 10 may contain a laser capable of marking the syringe directly, or a blank label on the syringe, with the necessary barcode information. Such a system may or may not require custom formulation of syringe material to incorporate photosensitive materials for use with the laser.
While this disclosure has been described as having exemplary designs, the present disclosure can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the disclosure using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this disclosure pertains and which fall within the limits of the appended claims.
The present application is a continuation of U.S. application Ser. No. 15/299,796, entitled “Tensioning Control Device”, filed Oct. 21, 2016, which is a continuation of U.S. application Ser. No. 14/878,509, entitled “Tensioning Control Device”, filed Oct. 8, 2015 (now U.S. Pat. No. 9,505,233), which claims priority to U.S. Provisional Application Ser. No. 62/062,279, entitled “Tensioning Control Device”, filed Oct. 10, 2014, the entire disclosures of each of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
607941 | Mayo | Jul 1898 | A |
614703 | Delory | Nov 1898 | A |
3430625 | McLeod, Jr. | Mar 1969 | A |
3835897 | Gess | Sep 1974 | A |
4003252 | Dewath | Jan 1977 | A |
4415802 | Long | Nov 1983 | A |
4801853 | Lewis et al. | Jan 1989 | A |
4853521 | Claeys et al. | Aug 1989 | A |
4857713 | Brown | Aug 1989 | A |
4921277 | McDonough | May 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
5040422 | Frankenberger et al. | Aug 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5179862 | Lynnworth | Jan 1993 | A |
5247826 | Frola et al. | Sep 1993 | A |
5317506 | Coutre et al. | May 1994 | A |
5429602 | Hauser | Jul 1995 | A |
5463906 | Spani et al. | Nov 1995 | A |
5531697 | Olsen et al. | Jul 1996 | A |
5531698 | Olsen | Jul 1996 | A |
5549401 | Ishikawa et al. | Aug 1996 | A |
5569212 | Brown | Oct 1996 | A |
5611784 | Barresi et al. | Mar 1997 | A |
5612524 | Sant' Anselmo et al. | Mar 1997 | A |
5628309 | Brown | May 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5692640 | Caulfield et al. | Dec 1997 | A |
5720733 | Brown | Feb 1998 | A |
5740428 | Mortimore et al. | Apr 1998 | A |
5782814 | Brown et al. | Jul 1998 | A |
5792117 | Brown | Aug 1998 | A |
5845264 | Nellhaus | Dec 1998 | A |
5873731 | Prendergast | Feb 1999 | A |
5882338 | Gray | Mar 1999 | A |
5925014 | Teeple, Jr. | Jul 1999 | A |
6106498 | Friedli et al. | Aug 2000 | A |
6123686 | Olsen et al. | Sep 2000 | A |
D438634 | Merry | Mar 2001 | S |
6249299 | Tainer | Jun 2001 | B1 |
6256037 | Callahan | Jul 2001 | B1 |
6336752 | Balopole et al. | Jan 2002 | B1 |
6341174 | Callahan et al. | Jan 2002 | B1 |
6342889 | Callahan | Jan 2002 | B1 |
6381029 | Tipirneni | Apr 2002 | B1 |
6422094 | Ganshorn | Jul 2002 | B1 |
6464667 | Kamen et al. | Oct 2002 | B1 |
6482185 | Hartmann | Nov 2002 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
RE38189 | Walker et al. | Jul 2003 | E |
6626355 | Sasse et al. | Sep 2003 | B2 |
6641562 | Peterson | Nov 2003 | B1 |
6644130 | Imai et al. | Nov 2003 | B2 |
6675660 | Mosier et al. | Jan 2004 | B1 |
6685227 | Merry et al. | Feb 2004 | B2 |
6685678 | Evans et al. | Feb 2004 | B2 |
6697067 | Callahan et al. | Feb 2004 | B1 |
6733495 | Bek et al. | May 2004 | B1 |
6742992 | Davis | Jun 2004 | B2 |
6798533 | Tipirneni | Sep 2004 | B2 |
6814254 | Liff et al. | Nov 2004 | B2 |
6825864 | Botten et al. | Nov 2004 | B2 |
6854338 | Khuri-Yakub et al. | Feb 2005 | B2 |
6985870 | Martucci et al. | Jan 2006 | B2 |
7000485 | Ao et al. | Feb 2006 | B2 |
7074209 | Evans et al. | Jul 2006 | B2 |
7077289 | Ross | Jul 2006 | B2 |
7106479 | Roy et al. | Sep 2006 | B2 |
7115113 | Evans et al. | Oct 2006 | B2 |
7116343 | Botten et al. | Oct 2006 | B2 |
7161488 | Frasch | Jan 2007 | B2 |
7175081 | Andreasson et al. | Feb 2007 | B2 |
7180624 | Tipirneni | Feb 2007 | B2 |
7182256 | Andreasson et al. | Feb 2007 | B2 |
7225683 | Harnett et al. | Jun 2007 | B2 |
7236936 | White et al. | Jun 2007 | B2 |
7237199 | Menhardt et al. | Jun 2007 | B1 |
7264323 | Tainer et al. | Sep 2007 | B2 |
7299981 | Hickle et al. | Nov 2007 | B2 |
7303467 | Birang et al. | Dec 2007 | B2 |
7319540 | Tipirneni | Jan 2008 | B2 |
7347841 | Elhadad et al. | Mar 2008 | B2 |
7358505 | Woodworth et al. | Apr 2008 | B2 |
7360448 | Maginnis et al. | Apr 2008 | B2 |
7375737 | Botten et al. | May 2008 | B2 |
7442181 | Schubert et al. | Oct 2008 | B2 |
7469598 | Shkarlet et al. | Dec 2008 | B2 |
7469599 | Froehlich et al. | Dec 2008 | B2 |
D588200 | Langan et al. | Mar 2009 | S |
7534239 | Schneider et al. | May 2009 | B1 |
D593613 | Langan et al. | Jun 2009 | S |
D595361 | Langan et al. | Jun 2009 | S |
7559483 | Hickle et al. | Jul 2009 | B2 |
7564579 | Tipirneni | Jul 2009 | B2 |
D597608 | Langan et al. | Aug 2009 | S |
D602534 | Langan et al. | Oct 2009 | S |
7614545 | Christoffersen et al. | Nov 2009 | B2 |
7617739 | Dam | Nov 2009 | B1 |
D605228 | Langan et al. | Dec 2009 | S |
D605229 | Langan et al. | Dec 2009 | S |
D605230 | Langan et al. | Dec 2009 | S |
7645258 | White et al. | Jan 2010 | B2 |
7673527 | Ehring et al. | Mar 2010 | B2 |
7694565 | Koerdt et al. | Apr 2010 | B2 |
7703336 | Genosar | Apr 2010 | B2 |
7704231 | Pongpairochana et al. | Apr 2010 | B2 |
7753880 | Malackowski | Jul 2010 | B2 |
7753891 | Tennican et al. | Jul 2010 | B2 |
7756724 | Gropper et al. | Jul 2010 | B2 |
7763006 | Tennican | Jul 2010 | B2 |
D621879 | Langan et al. | Aug 2010 | S |
D621880 | Langan et al. | Aug 2010 | S |
7776018 | Bush, Jr. et al. | Aug 2010 | B2 |
D624595 | Langan et al. | Sep 2010 | S |
D624596 | Langan et al. | Sep 2010 | S |
7799010 | Tennican | Sep 2010 | B2 |
7815123 | Conner et al. | Oct 2010 | B2 |
7815605 | Souter | Oct 2010 | B2 |
7819838 | Ziegler et al. | Oct 2010 | B2 |
7822096 | Kuksenkov | Oct 2010 | B2 |
7859473 | Gibson | Dec 2010 | B2 |
D633151 | Langan et al. | Feb 2011 | S |
7887513 | Nemoto et al. | Feb 2011 | B2 |
D634367 | Langan et al. | Mar 2011 | S |
D634368 | Langan et al. | Mar 2011 | S |
D634369 | Langan et al. | Mar 2011 | S |
7905861 | Rhinehart et al. | Mar 2011 | B2 |
7918830 | Langan et al. | Apr 2011 | B2 |
7927313 | Stewart et al. | Apr 2011 | B2 |
7933780 | De La Huerga | Apr 2011 | B2 |
7941949 | Cloninger | May 2011 | B2 |
D639861 | Langan et al. | Jun 2011 | S |
D639862 | Langan et al. | Jun 2011 | S |
D639863 | Langan et al. | Jun 2011 | S |
7967778 | Nemoto et al. | Jun 2011 | B2 |
D641421 | Langan et al. | Jul 2011 | S |
D641422 | Langan et al. | Jul 2011 | S |
7976508 | Hoag | Jul 2011 | B2 |
D643468 | Langan et al. | Aug 2011 | S |
D643469 | Langan et al. | Aug 2011 | S |
D643470 | Langan et al. | Aug 2011 | S |
D643471 | Langan et al. | Aug 2011 | S |
D643472 | Langan et al. | Aug 2011 | S |
7991627 | Hutchinson et al. | Aug 2011 | B2 |
D645094 | Langan et al. | Sep 2011 | S |
8031347 | Edwards et al. | Oct 2011 | B2 |
D649196 | Langan et al. | Nov 2011 | S |
8059297 | Tipirneni | Nov 2011 | B2 |
8063925 | Tainer et al. | Nov 2011 | B2 |
8065924 | Ziegler et al. | Nov 2011 | B2 |
8069060 | Tipirneni | Nov 2011 | B2 |
8111159 | Andreasson et al. | Feb 2012 | B2 |
8140349 | Hanson et al. | Mar 2012 | B2 |
8235938 | Eggers et al. | Aug 2012 | B2 |
8328082 | Bochenko et al. | Dec 2012 | B1 |
8355753 | Bochenko et al. | Jan 2013 | B2 |
8356434 | Alipour | Jan 2013 | B2 |
8385972 | Bochenko et al. | Feb 2013 | B2 |
8394053 | Bochenko et al. | Mar 2013 | B2 |
8494093 | Zhang | Jul 2013 | B1 |
8524333 | Fujinami | Sep 2013 | B2 |
8582171 | Srnka et al. | Nov 2013 | B2 |
8606596 | Bochenko et al. | Dec 2013 | B1 |
8639525 | Levine et al. | Jan 2014 | B2 |
8662626 | Kahl et al. | Mar 2014 | B2 |
8702674 | Bochenko | Apr 2014 | B2 |
8734039 | Castells et al. | May 2014 | B2 |
8752088 | Harvey et al. | Jun 2014 | B1 |
8945066 | Bochenko et al. | Feb 2015 | B2 |
9039655 | Prince et al. | May 2015 | B2 |
9044977 | McLaughlin et al. | Jun 2015 | B2 |
9078809 | Bochenko et al. | Jul 2015 | B2 |
9101534 | Bochenko | Aug 2015 | B2 |
20010020148 | Sasse et al. | Sep 2001 | A1 |
20010049608 | Hochman | Dec 2001 | A1 |
20010056258 | Evans | Dec 2001 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020099334 | Hanson et al. | Jul 2002 | A1 |
20020188259 | Hickle et al. | Dec 2002 | A1 |
20030055685 | Cobb et al. | Mar 2003 | A1 |
20030135388 | Martucci et al. | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030160698 | Andreasson et al. | Aug 2003 | A1 |
20030164401 | Andreasson et al. | Sep 2003 | A1 |
20040082918 | Evans et al. | Apr 2004 | A1 |
20040105115 | Edwards et al. | Jun 2004 | A1 |
20040179051 | Tainer et al. | Sep 2004 | A1 |
20040179132 | Fujino et al. | Sep 2004 | A1 |
20040193453 | Butterfield et al. | Sep 2004 | A1 |
20040212834 | Edwards et al. | Oct 2004 | A1 |
20040238631 | Andreasson et al. | Dec 2004 | A1 |
20050070978 | Bek et al. | Mar 2005 | A1 |
20050088306 | Andreasson et al. | Apr 2005 | A1 |
20050101905 | Merry | May 2005 | A1 |
20050118048 | Traxinger | Jun 2005 | A1 |
20050151652 | Frasch | Jul 2005 | A1 |
20050151823 | Botten et al. | Jul 2005 | A1 |
20050154368 | Lim et al. | Jul 2005 | A1 |
20050277873 | Stewart et al. | Dec 2005 | A1 |
20050277890 | Stewart et al. | Dec 2005 | A1 |
20060032918 | Andreasson et al. | Feb 2006 | A1 |
20060065713 | Kingery | Mar 2006 | A1 |
20060079843 | Brooks et al. | Apr 2006 | A1 |
20060102503 | Elhadad et al. | May 2006 | A1 |
20060143051 | Eggers et al. | Jun 2006 | A1 |
20060144942 | Evans et al. | Jul 2006 | A1 |
20060178617 | Adams et al. | Aug 2006 | A1 |
20060190302 | Eggers et al. | Aug 2006 | A1 |
20060206356 | Vanderveen | Sep 2006 | A1 |
20060224125 | Simpson et al. | Oct 2006 | A1 |
20060229551 | Martinez et al. | Oct 2006 | A1 |
20060270997 | Lim et al. | Nov 2006 | A1 |
20060287887 | Hutchinson et al. | Dec 2006 | A1 |
20070008399 | Botten et al. | Jan 2007 | A1 |
20070100316 | Traxinger | May 2007 | A1 |
20070134044 | Colbrunn et al. | Jun 2007 | A1 |
20070167919 | Nemoto et al. | Jul 2007 | A1 |
20070179448 | Lim et al. | Aug 2007 | A1 |
20070187475 | MacLeod | Aug 2007 | A1 |
20070191787 | Lim et al. | Aug 2007 | A1 |
20070255199 | Dewey | Nov 2007 | A1 |
20070280710 | Tainer et al. | Dec 2007 | A1 |
20070293830 | Martin | Dec 2007 | A1 |
20080043088 | Botten et al. | Feb 2008 | A1 |
20080071219 | Rhinehart et al. | Mar 2008 | A1 |
20080118141 | Sommer et al. | May 2008 | A1 |
20080191013 | Liberatore | Aug 2008 | A1 |
20080243088 | Evans | Oct 2008 | A1 |
20080255523 | Grinberg | Oct 2008 | A1 |
20080294108 | Briones et al. | Nov 2008 | A1 |
20080306439 | Nelson et al. | Dec 2008 | A1 |
20090018494 | Nemoto et al. | Jan 2009 | A1 |
20090043253 | Podaima | Feb 2009 | A1 |
20090112178 | Behzadi | Apr 2009 | A1 |
20090112333 | Sahai | Apr 2009 | A1 |
20090126866 | Stenner et al. | May 2009 | A1 |
20090137956 | Souter | May 2009 | A1 |
20090143673 | Drost et al. | Jun 2009 | A1 |
20090149744 | Nemoto et al. | Jun 2009 | A1 |
20090156931 | Nemoto et al. | Jun 2009 | A1 |
20090159654 | Grimard | Jun 2009 | A1 |
20090200185 | Follman et al. | Aug 2009 | A1 |
20090204028 | Richards | Aug 2009 | A1 |
20090259176 | Yairi | Oct 2009 | A1 |
20090288497 | Ziegler et al. | Nov 2009 | A1 |
20090296540 | Gilbert et al. | Dec 2009 | A1 |
20090306620 | Thilly et al. | Dec 2009 | A1 |
20100022953 | Bochenko et al. | Jan 2010 | A1 |
20100022987 | Bochenko et al. | Jan 2010 | A1 |
20100036310 | Hillman | Feb 2010 | A1 |
20100036313 | Shener et al. | Feb 2010 | A1 |
20100065633 | Nelson et al. | Mar 2010 | A1 |
20100076310 | Wenderow et al. | Mar 2010 | A1 |
20100095782 | Ferencz et al. | Apr 2010 | A1 |
20100114951 | Bauman et al. | May 2010 | A1 |
20100145165 | Merry | Jun 2010 | A1 |
20100194812 | Castells et al. | Aug 2010 | A1 |
20100204659 | Bochenko et al. | Aug 2010 | A1 |
20100280486 | Khair et al. | Nov 2010 | A1 |
20100286599 | Ziegler et al. | Nov 2010 | A1 |
20100305499 | Matsiev et al. | Dec 2010 | A1 |
20110009800 | Dam et al. | Jan 2011 | A1 |
20110009817 | Bennett et al. | Jan 2011 | A1 |
20110028937 | Powers et al. | Feb 2011 | A1 |
20110060198 | Bennett et al. | Mar 2011 | A1 |
20110111794 | Bochenko et al. | May 2011 | A1 |
20110112473 | Bochenko et al. | May 2011 | A1 |
20110112474 | Bochenko et al. | May 2011 | A1 |
20110137288 | Tallarida et al. | Jun 2011 | A1 |
20110152824 | DiPerna et al. | Jun 2011 | A1 |
20110152825 | Marggi | Jun 2011 | A1 |
20110152834 | Langan et al. | Jun 2011 | A1 |
20110161112 | Keefe et al. | Jul 2011 | A1 |
20110166511 | Sharvit et al. | Jul 2011 | A1 |
20110185821 | Genosar | Aug 2011 | A1 |
20110259954 | Bartz et al. | Oct 2011 | A1 |
20110264069 | Bochenko | Oct 2011 | A1 |
20110315611 | Fulkerson et al. | Dec 2011 | A1 |
20120004602 | Hanson et al. | Jan 2012 | A1 |
20120004637 | Krulevitch et al. | Jan 2012 | A1 |
20120006127 | Nielsen | Jan 2012 | A1 |
20120022458 | Oh et al. | Jan 2012 | A1 |
20120035535 | Johnson et al. | Feb 2012 | A1 |
20120037266 | Bochenko | Feb 2012 | A1 |
20120046295 | Charrier et al. | Feb 2012 | A1 |
20120065617 | Matsiev et al. | Mar 2012 | A1 |
20120199275 | Giuliani et al. | Aug 2012 | A1 |
20120287431 | Matsiev et al. | Nov 2012 | A1 |
20120323208 | Bochenko et al. | Dec 2012 | A1 |
20120325330 | Prince et al. | Dec 2012 | A1 |
20130018356 | Prince et al. | Jan 2013 | A1 |
20150211904 | Forster | Jun 2015 | A1 |
20150204705 | Forster et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
2487221 | May 2005 | CA |
101663173 | Mar 2010 | CN |
101830127 | Sep 2010 | CN |
202966821 | Jun 2013 | CN |
205293324 | Jun 2016 | CN |
2183046 | May 1987 | GB |
2504288 | Jan 2014 | GB |
2504295 | Jan 2014 | GB |
2504297 | Jan 2014 | GB |
6450935 | Mar 1989 | JP |
2117558 | May 1990 | JP |
3075464 | Nov 2000 | JP |
2005154061 | Jun 2005 | JP |
2006327199 | Dec 2006 | JP |
2010179932 | Aug 2010 | JP |
205154061 | Oct 2012 | JP |
201461647 | Apr 2014 | JP |
2007124821 | Nov 2007 | WO |
2009114115 | Sep 2009 | WO |
2010144482 | Dec 2010 | WO |
2011018804 | Feb 2011 | WO |
2012034084 | Mar 2012 | WO |
2014016311 | Jan 2014 | WO |
2014016315 | Jan 2014 | WO |
2014016316 | Jan 2014 | WO |
Number | Date | Country | |
---|---|---|---|
20190135474 A1 | May 2019 | US |
Number | Date | Country | |
---|---|---|---|
62062279 | Oct 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15299796 | Oct 2016 | US |
Child | 16238916 | US | |
Parent | 14878509 | Oct 2015 | US |
Child | 15299796 | US |